hotspot -WSS

hotspot

author：focus 2025-09-30 01:14:02 - browse：66529

An army of wooden figures under blue and pink lighting — biotech coverage from STAT — Adobe

In an abrupt change of course from plans earlier in the month, at-home test maker Cue Health is laying off all of its employees and shutting down as of Friday, May 24.

The company, which grew to prominence during the Covid-19 pandemic as the maker of one of the only molecular at-home tests for the virus, has been teetering on the edge of insolvency for months. The shutdown, first reported by the San Diego Union-Tribune, comes just over a week after the FDA warned consumers not to use Cue’s only FDA-authorized product, a Covid-19 test kit.

Cue had previously notified 49% of its workers on May 1 that they would be laid off from the company, effective July 1. But in a WARN notice filed with California state regulators on May 20, chief human resources officer Allison Blackwell said that due to the “fluid nature of this situation,” all U.S. employees who had not already received notice of termination would be receiving one. All employees will receive their last paychecks on May 24, the notice said.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Elevance, private equity launch primary care company

focus

WSS

3 hurdles to bringing medical devices to the U.S. market

First recipient of genetically engineered pig kidney has died

Making AI in medicine accessible to smaller, and rural hospitals

Sanofi strikes deal with Novavax, boosting the vaccine maker

Use wet bulb globe temperature, not heat index, to protect workers

Gene therapy has helped boys walk. Can scientists keep it that way?

focus

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Wikipedia

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Weight bias in eating disorder treatment complicated by new weight loss drugs

Novavax promises a turnaround & Lilly roils the obesity market

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

As demand for Covid shots wanes, Moderna seeks its next success

Paxlovid study fails to answer questions over benefit for broader groups

In Memoriam: Notable people who died in 2023

With FDA staff opposed to Sarepta therapy, top official intervened

Novavax promises a turnaround & Lilly roils the obesity market

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

focus

Why are elite athletes different? Take a look at their microbes

What would happen to your eyes if you looked at the solar eclipse?

Medicare says breakthrough device reimbursement rule to come by summer

Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

Gene therapy has helped boys walk. Can scientists keep it that way?

Researchers on aging grapple with how to calculate biological age

Wikipedia

explore

focus

explore